In a groundbreaking study that challenges existing paradigms in oncology, researchers at IRB Barcelona have uncovered a novel mechanism by which tumors characterized by chromosomal instability fuel their own growth. Published in EMBO Reports, this research elucidates a complex interaction between chromosomally unstable tumor cells and their surrounding healthy tissue, mediated by senescent cells that alter the microenvironment to the tumor’s advantage. This discovery not only enriches our understanding of tumor biology but also opens promising avenues for the development of targeted cancer therapies.
Chromosomal instability, a hallmark of many aggressive solid tumors, has long been associated with genetic alterations that propel tumor progression. Traditionally, the focus has been on how this instability changes the tumor genome—by adding oncogenes or deleting tumor suppressor genes—thereby directly influencing the tumor’s inherent proliferative capacity. However, Dr. Marco Milán’s team offers a paradigm shift, demonstrating that the consequences of chromosomal instability extend beyond the cancer cells themselves to profoundly impact the neighboring healthy tissues and systemic tumor dynamics.
Using the genetically tractable model organism Drosophila melanogaster, the researchers were able to visualize and analyze in vivo how cells harboring abnormal chromosome numbers—aneuploid cells—enter a state known as senescence. Despite their arrest in cell division, these senescent cells remain metabolically active and secrete a variety of signaling molecules. The study importantly reveals that these signals not only promote invasion and tumor growth but also inflict damage on adjacent non-tumorous cells, creating a deleterious environment that paradoxically benefits the tumor.
Senescence is generally regarded as a protective mechanism against malignant transformation. When cells detect irreparable damage, such as chromosome missegregation, they cease dividing to prevent the propagation of potentially harmful mutations. These senescent cells typically emit signals to recruit immune cells for tissue repair. Yet, when senescent cells persist, they adopt a secretory profile that can promote chronic inflammation and pathological conditions including cancer. This study specifically focuses on the senescence induced by aneuploidy, highlighting a conserved cellular response characterized by cell cycle arrest, activation of stress pathways, and enhanced secretion of bioactive molecules.
The team’s meticulous experiments identified a portfolio of molecules secreted by these aneuploid senescent cells that alter the behavior of neighboring healthy cells. These include dilp8, the Drosophila equivalent of the human hormone Relaxin, and ImpL2, homologous to human IGFBP7, both of which suppress the proliferation of adjacent cells. Simultaneously, cytokines such as Upd1 and Upd3—analogs of IL-6—and Eiger, functionally similar to tumor necrosis factor (TNF) in mammals, actively induce apoptosis in surrounding tissues.
This orchestrated inhibition of healthy cell proliferation coupled with cell death establishes a hostile microenvironment that paradoxically supports tumor expansion. “Our data suggest that the tumor manipulates nearby tissue not just to clear physical space but potentially to harvest nutrients released by dying cells, supporting its further growth,” explains Kaustuv Ghosh, co-first author of the paper. This feed-forward loop between the tumor and its host tissue expands on the traditional view of tumor progression as a purely cell-autonomous process.
The versatility of Drosophila melanogaster as a model system enabled the researchers to dissect the temporal and spatial dynamics of this tumor-host interaction in ways that would be challenging in mammalian systems. Despite evolutionary distance, many cellular processes implicated here—aneuploidy, senescence, inflammatory signaling—are conserved between flies and humans, underscoring the translational relevance of these findings.
Looking ahead, the research team aims to leverage single-cell transcriptomic technologies to unravel the heterogeneity within aneuploid senescent cells. It remains unknown whether distinct chromosomal alterations correspond to specialized roles in tumor promotion or interaction with the immune system. Such insights could ultimately refine therapeutic strategies, allowing selective targeting of pernicious senescent cell subtypes that sustain tumor progression.
Dr. Milán emphasizes that this work is built upon over a decade of research focused on chromosomal instability’s role in cancer. Previous studies by his group identified key secreted signaling molecules involved in tumor invasion and systemic physiological effects. This new research adds a crucial dimension by demonstrating how senescent cells contribute to the physical remodeling and metabolic exploitation of the tumor’s microenvironment.
The implications of this study extend beyond basic science and into potential clinical applications. Targeting the deleterious secretory phenotype of senescent cells has emerged as a promising strategy in oncology and age-related pathologies. By pinpointing specific signaling pathways, such as those involving Relaxin, IGFBP7, IL-6, and TNF analogs, therapeutic interventions could be developed to disrupt the tumor-host dialog that fuels aggressive cancer growth.
Furthermore, understanding how tumors induce senescence in surrounding tissues and exploit the resultant cell death for sustenance adds a new layer to designing intervention strategies. Approaches that prevent the induction of senescence or enhance the clearance of senescent cells might limit the destructive feedback loop that tumors leverage to their advantage.
This pioneering research represents a significant step forward in decoding the multifaceted ecology of tumors and their microenvironment. It underscores the importance of studying cancer not just as a cell-intrinsic disease, but as a pathological state emerging from complex intercellular and tissue-level interactions. As the field progresses, such insights will be invaluable in designing comprehensive, precision therapies that target both cancer cells and their supportive niche.
Subject of Research: Chromosomal instability, aneuploidy-induced cellular senescence, tumor microenvironment interactions
Article Title: A tumour-host feed-forward loop contributes to the growth of chromosomal instability-induced tumours
News Publication Date: June 5, 2026
Web References: http://dx.doi.org/10.1038/s44319-026-00811-7
References: Published in EMBO Reports
Image Credits: IRB Barcelona
Keywords: Chromosomal instability, Senescence, Tumor microenvironment, Aneuploidy, Drosophila melanogaster, Tumor growth, Inflammatory signaling, IL-6, TNF, Relaxin, IGFBP7
Tags: aneuploidy and tumor growthcancer cell competition with healthy cellschromosomal instability in cancerDrosophila melanogaster cancer modelEMBO Reports oncology studyIRB Barcelona cancer researchmechanisms of tumor progressionmicroenvironmental changes in solid tumorssenescent cells altering tumor microenvironmenttargeted cancer therapies for chromosomal instabilitytumor-host tissue interactionstumor-induced senescence in healthy cells
